Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Mar;68(3):1170-6.
doi: 10.1016/S0006-3495(95)80293-6.

Cross-linking of CD4 in a TCR/CD3-juxtaposed inhibitory state: a pFRET study

Affiliations

Cross-linking of CD4 in a TCR/CD3-juxtaposed inhibitory state: a pFRET study

G Szabó Jr et al. Biophys J. 1995 Mar.

Abstract

Instances when T cell activation via the T cell receptor/CD3 complex is suppressed by anti-CD4 Abs are generally attributed either to the topological separation of CD4-p56lck from CD3, or their improper apposition. Photobleaching fluorescence resonance energy transfer measurements permitted direct analysis of these alternatives on human peripheral blood lymphocytes. Distinction between changes of relative antigen densities or positioning was made possible by simultaneously recording donor and acceptor fluorescence in the energy transfer experiment performed on homogeneous populations of flow-sorted cells. We show here that CD4 stays in the molecular vicinity of CD3, while anti-CD3 stimulation is suppressed by anti-CD4 or cross-linked HIV gp120. Our data suggest that cross-linking of CD4 through particular epitopes is capable of inhibiting activation driven by Abs binding to specific sites on CD3 without major topological sequestration of the Ags, in such a way that additional positive signals will also be affected. Thus, these and other related cases of negative signaling via CD4 may be interpreted in terms of functional uncoupling rather than a wide physical separation of CD4 from the T cell receptor-CD3 complex.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Biol Chem. 1993 Aug 15;268(23):16875-8 - PubMed
    1. Immunol Today. 1993 Apr;14(4):177-83 - PubMed
    1. Mol Immunol. 1993 Dec;30(18):1689-94 - PubMed
    1. J Exp Med. 1985 Oct 1;162(4):1294-303 - PubMed
    1. Science. 1986 Nov 28;234(4780):1120-3 - PubMed

Publication types